Jinglei Wang Selected Research

Inflammation (Inflammations)

1/2022	Ang2-Targeted Combination Therapy for Cancer Treatment.
3/2017	Application of 3D-HyCoSy in the diagnosis of oviduct obstruction.
1/2014	Involvement of oxidative stress and inflammation in liver injury caused by perfluorooctanoic acid exposure in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinglei Wang Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 03/2017
3	Cerebral Hemorrhage 09/2023 - 12/2020
3	Inflammation (Inflammations) 01/2022 - 01/2014
2	Infections 05/2022 - 12/2019
2	Hypertension (High Blood Pressure) 06/2021 - 05/2019
1	Osteoporosis 03/2024
1	Pathologic Processes 12/2023
1	Splenomegaly 04/2023
1	Chemical and Drug Induced Liver Injury 04/2023
1	Hypoxia (Hypoxemia) 04/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Hematoma 10/2021
1	COVID-19 06/2021
1	Infarction (Infarctions) 01/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021
1	Ischemic Stroke 01/2021
1	Colonic Neoplasms (Colon Cancer) 11/2020
1	Burns 10/2019
1	Atrophy 12/2018
1	Cysts 03/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2020
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 10/2021
2	SaltsIBA 06/2021 - 05/2019
2	Capsules (Microcapsules)IBA 01/2020 - 09/2019
2	Gefitinib (Iressa)FDA Link 01/2020 - 09/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 09/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 09/2019
1	LigandsIBA 03/2024
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2023
1	EnzymesIBA 09/2023
1	CytokinesIBA 04/2023
1	dimethylacetamideIBA 04/2023
1	ChromiumIBA 05/2022
1	SugarsIBA 05/2022
1	CadmiumIBA 05/2022
1	Heavy MetalsIBA 05/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	Oxygen (Dioxygen)IBA 04/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	AngiopoietinsIBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	1- (2- hydroxyethyl)- 2- methyl- 5- nitroimidazole N-(5-carboxy-5-aminopentane)carbamateIBA 01/2022
1	Rho Guanine Nucleotide Exchange FactorsIBA 10/2021
1	hepsinIBA 10/2021
1	Leucine (L-Leucine)FDA Link 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 10/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2021
1	OsteopontinIBA 10/2021
1	Green Fluorescent ProteinsIBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	triphenyltetrazoliumIBA 01/2021
1	HomocysteineIBA 12/2020
1	Nanoparticle Drug Delivery SystemIBA 11/2020
1	SolventsIBA 10/2020
1	Sorafenib (BAY 43-9006)FDA Link 10/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020
1	AcidsIBA 01/2020
1	Liposomes (Liposome)IBA 01/2020
1	jasmonic acid (jasmonate)IBA 12/2019
1	CalciumIBA 10/2019
1	Circular RNAIBA 10/2019
1	Biocompatible Materials (Biomaterials)IBA 09/2019
1	ChitosanIBA 09/2019
1	GlucansIBA 09/2019
1	Poloxamer (Poloxamer 407)IBA 09/2019
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 09/2019
1	Diethylhexyl Phthalate (DEHP)IBA 12/2018
1	Contrast MediaIBA 03/2017
1	perfluorooctanoic acidIBA 01/2014

Therapy/Procedure

4	Therapeutics 04/2023 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Aftercare (After-Treatment) 04/2023
1	Radiotherapy 01/2022
1	Photothermal Therapy 01/2022
1	Precision Medicine 01/2022
1	Immunotherapy 01/2022
1	Transplantation 01/2021
1	Quantum Dots (Quantum Dot) 01/2020